These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8531651)

  • 41. Circulating antigens for assessing cure in schistosomiasis mansoni.
    Madwar MA; Hassan MM; Strickland GT
    Trans R Soc Trop Med Hyg; 1988; 82(6):881-4. PubMed ID: 3151529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic regeneration after partial hepatectomy in mice infected with Schistosoma mansoni, at the acute and chronic phases of the disease.
    Costa G; Cunha-Melo JR; Aguiar BG; Gonçalves SC; Toppa NH; Coelho PM
    Rev Inst Med Trop Sao Paulo; 1999; 41(4):255-8. PubMed ID: 10564921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survey on the clinical trial results achieved in Brazil comparing praziquantel and oxamniquine in the treatment of mansoni schistosomiasis.
    de Rezende GL
    Rev Inst Med Trop Sao Paulo; 1985; 27(6):328-36. PubMed ID: 3939162
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of oxamniquine, praziquantel and a combination of both drugs in schistosomiasis mansoni in Brazil.
    Zwingenberger K; Queiroz JA; Poggensee U; Alencar JE; Valdegunas J; Esmeralda F; Feldmeier H
    Rev Inst Med Trop Sao Paulo; 1987; 29(5):305-11. PubMed ID: 3136533
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
    Fallon PG; Doenhoff MJ
    Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alternate chemotherapy in experimental schistosomiasis.
    Ismail MM; Farghaly AM; Hassan MM; Youssef SM; Mohamed FE
    J Egypt Soc Parasitol; 1992 Aug; 22(2):321-6. PubMed ID: 1500769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire.
    Polderman AM; Gryseels B; De Caluwe P
    Trans R Soc Trop Med Hyg; 1988; 82(1):115-6. PubMed ID: 3140441
    [No Abstract]   [Full Text] [Related]  

  • 48. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice.
    Doenhoff MJ; Sabah AA; Fletcher C; Webbe G; Bain J
    Trans R Soc Trop Med Hyg; 1987; 81(6):947-51. PubMed ID: 3140436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine.
    Costa G; Aguiar BG; Coelho PM; Cunha-Melo JR
    Acta Trop; 2003 Dec; 89(1):13-6. PubMed ID: 14636977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1985 Dec; 60(3):348-54. PubMed ID: 3935473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of worm burdens in experimental schistosomiasis.
    Fulford AJ; Yeang F
    Parasitology; 1988 Oct; 97 ( Pt 2)():303-15. PubMed ID: 3143991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudoneoplastic lesion of the breast caused by Schistosoma mansoni.
    Lima CA; Cavalcanti AC; Lima MM; Piva N
    Rev Soc Bras Med Trop; 2004; 37(1):63-4. PubMed ID: 15042188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic effect of praziquantel enantiomers in mice infected with Schistosoma mansoni.
    Xiao S; Chollet J; Booth M; Weiss NA; Tanner M
    Trans R Soc Trop Med Hyg; 1999; 93(3):324-5. PubMed ID: 10492771
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of specific treatment on the morbidity of Schistosomiasis mansoni in an endemic area of Minas Gerais, Brazil.
    Conceicao MJ; Borges-Pereira J
    Mem Inst Oswaldo Cruz; 2002 Jul; 97(5):755-7. PubMed ID: 12219148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
    Nessim NG; Demerdash Z
    Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-blind therapeutical evaluation based on the quantitative oogram technique, comparing praziquantel and oxamniquine in human schistosomiasis mansoni.
    da Cunha AS; Pedrosa RC
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):337-51. PubMed ID: 3109000
    [No Abstract]   [Full Text] [Related]  

  • 57. Schistosomiasis mansoni of the bladder simulating bladder cancer: a case report.
    Casella ML; Fanni VS; Verndl DO; Basso MC; Mello LF; Glina S
    Rev Soc Bras Med Trop; 2009; 42(5):581-2. PubMed ID: 19967243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lethal effect of oxamniquine and praziquantel on mice experimentally infected with Schistosoma mansoni.
    Tonelli SM; Goulart EM; Tonelli E; Coelho PM
    Rev Inst Med Trop Sao Paulo; 1995; 37(4):361-3. PubMed ID: 8599068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.
    Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD
    Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meckel's diverticulitis associated with Schistosoma mansoni.
    Sood R; Green MR; McKeever PA; Johnstone JM
    J Pediatr Gastroenterol Nutr; 1999 Mar; 28(3):336-7. PubMed ID: 10067741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.